DRUG FIRM MOVES TO BLOCK RX IMPORTS

MARLTON, N.J. -- Cheap prescriptions from Canada are becoming a big business, with estimates placing its value as high as $650 million, but last month GlaxoSmithKline here launched an initiative to staunch the flow.The drug maker implemented a plan to halt the supply of prescription drugs to Canadian pharmacies that export to the United States. This latest development is another attempt to stop the

MARLTON, N.J. -- Cheap prescriptions from Canada are becoming a big business, with estimates placing its value as high as $650 million, but last month GlaxoSmithKline here launched an initiative to staunch the flow.

Register to view the full article